IDEAYA Biosciences Debt 2024

IDEAYA Biosciences Aktienanalyse

What does IDEAYA Biosciences do?

IDEAYA Biosciences Inc is a biotechnology company focused on the development of cancer therapies. The company was founded in 2015 by Yujiro S. Hata and is headquartered in South San Francisco, California. IDEAYA's business model consists of the discovery and development of precision medicine products based on targeted therapies. Targeted therapies are cancer treatments that aim at the specific characteristics of the tumor and have less harmful effects on normal tissue than traditional chemotherapeutics. IDEAYA specializes in the research and development of cancer drugs in three different areas: precision medicine, synthetic lethality, and resistance mechanisms. The company collaborates closely with leading experts in cancer research to develop innovative therapies. In the field of precision medicine, IDEAYA focuses on the development of products based on genetic alterations that cause specific tumors. These genetic alterations are unique to each type of cancer and each individual, meaning that precision medicine products must be individually tailored to each type of cancer. In the area of synthetic lethality, IDEAYA examines the interactions between cancer cells and their environment. These interactions can involve genetic or proteomic changes that make cancer cells dependent on certain signaling pathways and metabolic processes. IDEAYA develops drugs that exploit these dependencies to block the growth of cancer cells. In the area of resistance mechanisms, IDEAYA investigates the mechanisms that cancer cells develop to become resistant to cancer drugs. This involves the discovery of compounds that can bypass these mechanisms and make the cancer cells sensitive to treatments again. IDEAYA has several products in the pipeline, including Inhibat (IDE196) and polyclonal antibodies. Inhibat (IDE196) is a potent and highly selective BRAF inhibitor used in clinical trials for cancer. Polyclonal antibodies are monoclonal antibodies used in cancer immunotherapy. IDEAYA is a company focused on the development of innovative cancer drugs. The company has a solid foundation in cancer research and works closely with leading experts to develop innovative therapies. The company has several products in the pipeline and is working hard to make a significant contribution in cancer research. IDEAYA Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding IDEAYA Biosciences's Debt Structure

IDEAYA Biosciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing IDEAYA Biosciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to IDEAYA Biosciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in IDEAYA Biosciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about IDEAYA Biosciences stock

What is the debt of IDEAYA Biosciences this year?

IDEAYA Biosciences has a debt level of -157.02 USD this year.

What was the debt of IDEAYA Biosciences compared to the previous year?

The debt of IDEAYA Biosciences has increased by 128.89% compared to the previous year increased.

What are the consequences of high debt for investors in IDEAYA Biosciences?

High debt can pose a risk for investors of IDEAYA Biosciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of IDEAYA Biosciences?

Low debt means that IDEAYA Biosciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from IDEAYA Biosciences affect the company?

An increase in debt of IDEAYA Biosciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of IDEAYA Biosciences affect the company?

A reduction in debt of IDEAYA Biosciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of IDEAYA Biosciences?

Some factors that can influence the debt of IDEAYA Biosciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of IDEAYA Biosciences so important for investors?

The debts of IDEAYA Biosciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can IDEAYA Biosciences take to change the debt?

To change the debt, IDEAYA Biosciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does IDEAYA Biosciences pay?

Over the past 12 months, IDEAYA Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEAYA Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEAYA Biosciences?

The current dividend yield of IDEAYA Biosciences is .

When does IDEAYA Biosciences pay dividends?

IDEAYA Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEAYA Biosciences?

IDEAYA Biosciences paid dividends every year for the past 0 years.

What is the dividend of IDEAYA Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEAYA Biosciences located?

IDEAYA Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEAYA Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEAYA Biosciences from 8/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.

When did IDEAYA Biosciences pay the last dividend?

The last dividend was paid out on 8/2/2024.

What was the dividend of IDEAYA Biosciences in the year 2023?

In the year 2023, IDEAYA Biosciences distributed 0 USD as dividends.

In which currency does IDEAYA Biosciences pay out the dividend?

The dividends of IDEAYA Biosciences are distributed in USD.